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Abstract A new vesicle system is described that combines 
complementary properties of liposomes and polymeric beads. 
'Lipobeads' consist of a lipid bilayer shell anchored on the 
surface of a hydrogel polymer cores which acts like a 
cytoskeleton. Anchoring is provided by fatty acids covalently 
attached to the surface of the hydrogel. These hydrophobic 
chains drive spontaneous assembly of a lipid bilayer shell around 
the modified hydrogel bead when exposed to a suspension of 
liposomes. The bilayer is stable and acts as a permeability barrier 
to compound loaded by prior absorption into the polymer core. 
Lipid mobility in the shell is similar to that found in other 
unanchored lipid hilayers. The system has potential application in 
drug delivery and for functional reconstitution of membrane 
proteins. 
Key words: Supported lipid bilayer; Hydrogel microsphere; 
Polyvinyl alcohol; Liposome; Model membrane; Artificial 
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I. Introduction 
Artificial particulate systems uch as polymeric beads and 
liposomes are finding a variety of biomedical applications in 
drug delivery, drug targeting, protein separation, enzyme im- 
mobilization and blood cell substitution [1-6]. Liposomes 
have a flexible, cell-like lipid bilayer surface which acts as a 
permeability barrier such that compounds can be entrapped in
their aqueous interior. However, liposomes can be mechani- 
cally unstable and their loading capacity limited by the water 
solubility of the material to be loaded [7]. Polymeric beads, 
although mechanically more stable and having a larger load- 
ing capacity then liposomes, lack many of the useful surface 
properties of a lipid bilayer shell. Here, we describe the prep- 
aration and characterization a new hybrid vesicle system 
with structural similarity to natural cells that combines com- 
plementary advantages of liposomes and polymeric beads. 
This system, which we have called 'Lipobeads', consists of a 
lipid bilayer shell that is anchored on the surface of a hydrogel 
polymer core. 
Lipid bilayers upported on various solid surfaces, such as 
glass [8], plastic [5], and metal [9] as well as modified polymers 
[10] have previously been shown to provide a stable and well 
defined cell membrane-like environment that has found a 
number of basic and applied uses [11,12]. It was, therefore 
reasonable to expect hat assembly of lipid bilayers on spher- 
ical hydrogel surfaces could be a useful approach for prepar- 
ing an artificial cell analogue. Indeed, in 1987, Gao and 
Huang [13] reported that encapsulation f hydrogel particles 
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into liposomes enhanced the loading capacity and overall me- 
chanical strength of the liposomal structure. However, in that 
system the unanchored bilayer is still somewhat unstable and 
the system could only be formed with specific lipid mixtures 
and only with polymer cores of certain sizes and shapes. We 
have developed a hydrogel anchored liposome in which these 
limitations have been overcome. 
Our approach (see Fig. 1) has been to create hydrophobic 
anchors for the bilayer by attaching lipid molecules to the 
surface of pre-formed polyvinyl alcohol (PVA) xerogel (dry 
hydrogel) beads. When the surface modified xerogel is then 
hydrated and treated with a liposome suspension the hydro- 
phobic lipid molecules and other intrinsic membrane compo- 
nents of the liposomes associate spontaneously with the hy- 
drophobic fatty acid anchors on the surface of the hydrated 
polymer and self-organize into a distributed membrane over 
that surface through ydrophobic nteractions. Thus, not only 
do these anchors add mechanical stability to the bilayer shell 
but they also promote its self-assembly. In a sense, these acyl 
anchors and the polymer to which they are attached act as a 
'cytoskeleton'. This self-assembly property allows the bilayer 
coating to be established on cores ranging in shape from 
sheets to spheres. 
2. Materials and methods 
PVA was chosen as the hydrogel support because of its proven bio- 
compatibility [14,15]. In addition, PVA can be physically cross-linked 
[16] so that drugs of large molecular weight can be incorporated into 
the hydrogel matrix via an absorptive loading process after the beads 
are made, avoiding exposure to other chemical reagents which might 
alter the properties of the incorporated drug. Furthermore, the high 
content of hydroxyl groups of PVA enables the hydrophobic anchor 
molecules to be covalently attached at a sufficiently high surface den- 
sity to drive spontaneous a sembly of a surface lipid bilayer. 
PVA was formed into beads by dispersal in paraffin, freeze-thaw 
solidification and in situ drying facilitated by bubbling dry air through 
the suspension. Fully hydrolyzed polyvinyl alcohol (PVA) (Elvanol 
71-30, from Dupont) with Mw 116000 and Mn 39500 [17] was dis- 
solved in hot water at a concentration f 22% w/v and then dispersed 
in paraffin oil (Aldrich) containing 1.5% w/v surfactant (Span 80, 
Sigma) to form beads. The beads were then cross-linked by slowly 
freezing the suspension to -20°C for 12 h followed by a slow thaw at 
room temperature. The beads were then dried by bubbling dry air into 
the suspension for 1~ weeks, followed by removal of the oil through 
re-suspension in hexane, ethyl acetate and alcohol. This procedure 
produced Polyvinyl alcohol (PVA) xerogel spheres ranging in size 
from a few micrometers to over 100 ~trn in diameter. Spherical beads 
ranging in size from 70 to 90 ~tm were selected by sieving for further 
modification. 
Surface acylation with fatty acid chains was accomplished bytreat- 
ing the PVA beads with 1 M palmitoyl chloride (Aldrich) in hexane at 
room temperature for2 3 days. The palmitic species became anchored 
on the bead via esterification with surface hydroxyls. The completion 
of this reaction was characterized using attenuated total reflectance 
(ATR) FTIR and X-ray photoelectron spectroscopy (XPS). With 
ATR-FITR, the formation of an ester bond was determined, and 
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Fig. 1. Outline of lipobead preparation. The surface of pre-formed polyvinyl alcohol (PVA) xerogel (dry hydrogel) beads is exposed to chloro 
fatty acids dissolved in hexane which form ester linkages with surface hydroxyls on the xerogel and provide hydrophobic anchors for the bi- 
layer coating. Final formation of lipobeads was accomplished by adding the surface modified beads to a liposome suspension which leads to 
transfer of lipid onto the acylated surface of the bead and self-assembly of an anchored bilayer shell around the hydrogel core. 
with XPS, changes in atomic ratio at the surface was measured. For 
sampling the surfaces with these analytical tools, PVA films were 
subjected to identical chemical treatment as described above and sum- 
marized in Fig. 1. ATR-FITR spectra were recorded on a Bio-Rad 
Digilab FTS-7 system with a custom designed sample holder with 
which the polymer films were pressed against a Ge prism (25 x 5 x 1 
mm with 45 ° slope of the edge) and XPS spectra recorded on a 
Leybold MX-200 system with a Mg source, beam energy of 12 kV 
and beam current of 25 mA. Further details of the surface modifica- 
tion reactions and characterization procedures will be published else- 
where but indicate complete derivatisation of surface hydroxyls with 
little evidence of penetration beyond 10 nm (Jin and Lee, in prepara- 
tion). 
Final formation of lipobeads was accomplished bycombining equal 
parts of a suspension of surface modified beads to a liposome suspen- 
sion (made by sonicating a 5 mg/ml suspension ofphosphatidylcholine 
until transparent). The hydrophobicity of the acylated bead surface 
leads to transfer of lipid onto this surface and self-assembly of a 
bilayer shell around the hydrogel core. 
The uniformity, lateral mobility and permeability of the supported 
bilayer to ions and model drugs were examined using an MRC-600 
Laser Scanning Confocal Microscope (LSCM). 
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Fig. 2. Lateral mobility in hydrogel supported lipid bilayer labeled with fluorescent phospholipid. (A) Confocal images taken before and after a 
portion of a lipobead surface was photobleached. Time of capture is indicated below each image. (B) Time course of recovery of fluorescence 
in the photo-bleached area. The solid line describes the expected recovery based on an earlier time approximation [21] assuming a lipid diffu- 
sion coefficient of 1.55 x 10 -9 cm2/s. 
3. Results 
When dried acylated beads are placed in water, their diam- 
eter increases about 1.4-times at swelling equilibrium. How- 
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Fig. 3. Release of Lucifer yellow from lipobeads and bare PVA 
beads. Lucifer yellow was loaded by impregnating acylated and bare 
PVA beads with a solution of 50 ~M Lucifer yellow in 100 mM 
KC1. Loaded lipobeads, were then formed by liposome treatment. 
The graph depicts the time course of release of Lucifer yellow from 
the beads, measured in terms of the decay of fluorescence intensity 
after a dilution to 10/aM Lucifer yellow. 
ever, the beads aggregate and float on the water surface due to 
their surface hydrophobicity. Adding a liposome suspension 
to the solution with floating beads causes the beads to sepa- 
rate and sink to the bottom. These observations are consistent 
with contact angle measurements. For acylated PVA surfaces, 
the observed angle was 103 ° indicating that the surface is 
hydrophobic. The contact angle of the surface was reduced 
to less than 15 ° after the film was treated with liposomes. 
When beads are separated from water by filtration and ex- 
posed to air, the bilayer is disrupted and the beads again 
become hydrophobic. This process of bilayer formation and 
destruction can be easily repeated with the same sample de- 
monstrating the capability of lipobeads for self-repair. 
Measurement of Langmuir-Blodget (LB) film deposition on 
PVA disks subjected to the same surface modification as lipo- 
beads suggests that a single well-packed lipid layer is formed 
on the modified surface. For LB deposition, dioleoylphospha- 
tidylcholine (from Avanti Polar Lipids, and diluted with 
chloroform to 5 mM prior to use) was spread over the water 
surface of an LB trough (Mgw Lauda Filmwaage) to form a 
monolayer with membrane pressure of 30 dyn/cm. When the 
hydrophobic film is gradually dipped into of the water 
through the monolayer, a layer of lipid is deposited on the 
film as indicated by the decrease in monolayer surface area. 
Another layer is deposited when the film is withdrawn but, 
this second layer is easily stripped from the film surface when 
the sample is passed back through the monolayer surface, 
indicating that lipid multilayers are not formed. This result 
suggests to us that the lipobead coating is a bilayer with the 
interior leaflet anchored by the surface fatty acid residues. The 
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Fig. 4. Release of Ca 2+ from lipobeads and bare PVA beads loaded with fluo-3. Lipobeads and bare PVA beads loaded with 50 t.tM fluo-3 in 
a 'Ca 2+' medium subjected to a 5-fold dilution with '0 Ca 2+ medium' (see Section 2) which should reduce free extracellular Ca 2+ to 60 nM. 
Numbers below the images indicate relative fluorescence intensity. (A) Lipid layer on lipobeads prevents Ca 2+ efflux until an ionophore is 
added. Images of the same bead before dilution and 20 min after dilution, and 2 and 20 min after addition of the Ca 2+ ionophore, 4-bromo- 
A23187 (5 mM in methanol to reach a final concentration f 50 ~tM). (B) Bare PVA beads do not trap Ca 2+. Images of a bare bead before di- 
lution and at the times indicated after dilution. Color scale is from 0 to 250%. 
result also illustrates that the bilayer can be anchored on any 
shape of surface from planar to spherical. 
Fig. 2A show LSCM images of lipobeads treated with lipo- 
somes which contained 5% of the fluorescent membrane 
probe, 7-nitrobenz-2-oxa-l,3-diazol-4-yl (NBA) labeled di- 
oleoylphosphatidylethanolamine. The continuous ring of fluo- 
rescence suggests that following deposition, liposome phos- 
pholipid becomes evenly distributed over the lipobead 
surface. This observation is in keeping the considerable lateral 
mobility expected for lipid bilayers [18,19]. The fluidity of the 
supported bilayer was tested using a photo-bleaching proto- 
col. The LSCM laser beam was parked over a portion of the 
bead to induce local photo-bleaching of the fluorescence 
probe causing an opening in the ring of fluorescence (Fig. 
2A). This opening gradually closed over 15 min. Since 
photo-bleaching of NBA is irreversible [19,20], this recovery 
is attributable to the diffusion of labeled lipid molecules 
through the bilayer into the bleached region. Fig. 2B shows 
the time course of fluorescence r covery in the bleached area. 
The solid line is that expected for one-dimensional (slab) dif- 
fusion of labeled phospholipid from non-bleached area assum- 
ing a diffusion coefficient of 1.55 × 10 -9 cm2/s. This value is of 
the same order of magnitude as that estimated for normal 
lipid bilayers [18,19]. One-dimensional diffusion was consid- 
ered because the bleached region produced by the laser is 
expected to be several fold broader along the z-axis than in 
the confocal plane. 
For examining the permeability of the supported bilayer a 
fluorescent dye, Lucifer yellow, was used as a model com- 
pound in that its physical-chemical properties are similar to 
those of many small, hydrophilic drugs. Both lipobeads and 
bare PVA beads without hydrophobic surface anchors loaded 
with Lucifer yellow were added to dye free solution and dye 
efflux was followed. The fluorescence intensity changes for 
both lipobeads and bare beads after a 5-fold dilution are 
plotted versus time in Fig. 3. For the bare beads, the loaded 
Lucifer yellow was rapidly released and reached an equilib- 
rium in a few minutes. With lipobeads, however, the fluores- 
cence intensity decreased only slightly over 60 min. It is clear 
that small hydrophilic molecules can be entrapped in these 
lipobeads by the lipid coating. 
Fig. 4 illustrates the ability of lipobeads to trap ions. We 
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used the fluorescent indicator dye fluo-3 (Molecular Probes) 
to monitor levels of Ca 2÷ [22] trapped in the core of lipobeads 
by prior loading. Fig. 4A shows the fluorescence confocal 
images taken of lipobeads and bare PVA beads loaded with 
50 ~tM fluo-3 in a 'Ca 2+' medium which contained (in mM): 
2 CaC12, 1 EGTA, 5 HEPES, 140 KC1 with pH adjusted to 
7.4. The bathing solution was diluted 5-fold with a '0 Ca 2+ 
medium' identical to the Ca 2+ medium except hat the CaC12 
was omitted. This 5-fold dilution changes the ratio of Ca 2+ to 
EGTA such that extracellular f ee Ca 2+ levels should be re- 
duced from 1 mM to 60 nM. With the Lipobeads, the fluor- 
escence intensity of fluo-3 remained constant during the initial 
20 min of incubation in the low Ca 2+ medium but quickly 
decreased after adding a Ca 2+ ionophore, 4-bromo-A23187 
[22] (1:100 dilution (v/v) of 5 mM ionophore dissolved in 
methanol) to bypass the permeability barrier created by the 
bilayer coating. Adding the ionophore vehicle (methanol) 
alone to the same sample caused no change in fluorescence 
intensity (not shown), excluding possibility that the bilayer 
membrane was simply disrupted by the solvent. We conclude 
that the decrease in fluorescence is due to facilitated Ca 2+ 
diffusion across the bilayer membrane mediated by the iono- 
phore. Fig. 4B shows confocal images of bare PVA beads 
loaded with Ca 2+ and fluo-3. The same 5-fold dilution with 
zero Ca 2+ medium, caused the fluorescence intensity to de- 
crease rapidly in the initial 2 min, followed by a more gradual 
decay (Fig. 4B). These two components of fluorescence decre- 
ment may be attributed to the loss of Ca 2+ and fluo-3, respec- 
tively. These results indicate that the lipid coating on the 
beads provides a permeability barrier to hydrophilic ions 
such as Ca 2+. 
4. Discussion 
Lipobeads may potentially be useful in several novel bio- 
medical applications. As a drug carrier, for example, lipo- 
beads should be superior to liposomes in the sense of en- 
hanced mechanical stability, controllable size and increased 
drug loading capability. Long-term storage is possible since 
acylated beads loaded with drug can be stored in a dry form 
before lipid coating. Also, many of the techniques developed 
for liposomes uch as stimulus-sensitive drug release [23], ster- 
ic stabilization [24] and receptor or antibody mediated rug 
targeting [7] should still be applicable with lipobeads. Another 
potential application of lipobeads is red cell substitution. For 
hemoglobin (Hb) to perform a conformational change so that 
oxygen can be released readily at sites of low pO2, encapsula- 
tion of Hb with the cofactor, 2,3-DPG is required [6]. Com- 
bined loading with multiple compounds can be achieved be- 
fore adding the lipid membrane coating and much less lipid 
will be needed to entrap a given amount of Hb. By combining 
the structural features of liposomes and hydrogels, lipobeads 
may provide a more realistic red cell replacement while at the 
same time having a much higher encapsulating efficiency than 
liposomes. Since supported lipid bilayers have been found to 
create a favorable nvironment for receptor and enzyme func- 
tions [25], lipobeads may also provide a model environment 
for studying and simulating various biological functions uch 
as cell-cell interactions and the operation of purified and re- 
constituted trans-membrane proteins uch as ion channels and 
transporters. 
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